Karim El Khatib

Department of Medicine, Mohammed V University, Morocco, South Africa


  • Research Article   
    Interest of Botulinum Toxin in the Treatment of Temporomandibular Disorder
    Author(s): Saida El Khayati*, Jalal Hamama, Karim El Khatib and Amal El yamani

    Temporomandibular Disorders (TMD) refer to a group of debilitating masticatory conditions that are often associated with considerable morbidity and a reduction in a person’s quality of life. Approximately 44% of the population are affected, but only a quarter of them seek professional help. The aim of this review was to critically investigate and assess the evidence relating to the use and efficacy of Botulinum Toxin (BTX) in the management of temporomandibular joint disorders and masticatory myofascial pain. A comprehensive search was conducted of PubMed, Scopus, Embase, and Cochrane central, to find relevant studies from the last 30 years up to the end of April 2021, using the following Mesh terms: Botulinum Toxin, Temporomandibular Joint Disorders. Despite the demonstrated benefits, a consensus on the therapeutic benefit of BTX in the management of TMD.. Read More»

    Abstract HTML PDF